The company aims to start a pivotal trial this year, file for 510(k) clearance in 2027 and launch the device in 2028.

Insulet (Nasdaq:PODD) shared new clinical evidence for its first fully closed-loop automated insulin delivery system for type 2 diabetes.

Insulet Presents Promising Study Results for Fully Closed-Loop Automated Insulin Delivery System for Adults with Type 2 ...

Young children using the t:slim X2 insulin pump with Control-IQ Technology system maintained target glucose levels for 3 hours longer than children using an insulin pump or daily injections with a ...

Insulet said results from its study of a fully closed-loop automated insulin delivery system for type 2 diabetes shows an improvement over standard injection therapy. Insulet said its system showed 68 ...

Lower indirect costs and a lower incidence of serious complications offset the higher cost of the advanced hybrid closed-loop insulin system. Advanced hybrid closed-loop insulin monitoring and ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. NEW ORLEANS — New data show sustained glycemic ...

HAMBURG, Germany -- A hybrid closed-loop insulin therapy system significantly improved glycemic control among pregnant women with type 1 diabetes, the randomized AiDAPT trial showed. Meeting the ...

Tests in animals show the material works like the body's own system. Post content hidden for low score. Show… Post content hidden for low score. Show… Seems like a pretty interesting idea. I know a ...

Closed-loop insulin delivery systems, designed to automate aspects of diabetes management in children and teenagers, yielded significantly higher blood glucose time in range for children with type 1 ...

CHICAGO—Closed-loop insulin delivery systems improve glucose control in children with type 1 diabetes without causing adverse effects, according to a study presented Saturday at ENDO 2023, the ...